000			07636cam a2200517 i 4500
999			_c92094 _d92094
005			20250826090243.0
006			m o d
007			cr |||||||||||
008			250826t20222022njum ob u001 0 eng
020			_a9781119701071
020			_a9781119701101 _q(electronic bk. : oBook)
020			_a1119701104 _q(electronic bk. : oBook)
020			_a9781119701118 _qelectronic book
020			_a1119701112 _qelectronic book
020			_a9781119701088 _qelectronic book
020			_a1119701082 _qelectronic book
020			_z9781119701071 _qpaperback
024	7		_a10.1002/9781119701101 _2doi
035			_a(OCoLC)1260168362
040			_aDLC _beng _erda _cDLC _dOCLCO _dYDX _dOCLCF _dDG1 _dOCLCO
041			_aeng
042			_apcc
050	0	0	_aRM302.5 _b.T49 2022
060	0	0	_aQV 771
082	0	0	_a615.7/042 _223
245	0	0	_aTextbook of pharmacoepidemiology / _cedited by Brian L. Strom, Stephen E. Kimmel, Sean Hennessy.
250			_aThird edition.
264		1	_aHoboken, NJ : _bJohn Wiley & Sons, Inc., _c2022.
264		4	_c©2022.
300			_a1 online resource (xxv, 528 pages) : _billustrations (some color)
336			_atext _btxt _2rdacontent.
337			_acomputer _bc _2rdamedia.
338			_aonline resource _bcr _2rdacarrier.
504			_aIncludes bibliographical references and index.
505	0		_aTable of Contents Contributors Preface Acknowledgements Part I Introduction to Pharmacoepidemiology 1 What is Pharmacoepidemiology? Brian L. Strom 2 Study Designs Available for Pharmacoepidemiologic Studies Brian L. Strom 3 Sample Size Considerations for Pharmacoepidemiologic Studies Brian L. Strom 4 Basic Principles of Clinical Pharmacology Relevant to Pharmacoepidemiologic Studies Jeffrey S. Barrett 5 When Should One Perform Pharmacoepidemiologic Studies? Brian L. Strom 6 Views from Academia, Industry, Regulatory Agencies, and the Legal System Joshua J Gagne, Jerry Avorn, Nicolle M Gatto,Jingping Mo, Gerald J. Dal Pan, June Raine, Shinobu Uzu, Aaron S. Kesselheim, Kerstin N. Vokinger Part II Sources of Pharmacoepidemiology Data 7 Postmarketing Spontaneous Pharmacovigilance Reporting Systems Gerald J. Dal Pan, Marie Lindquist, and Kate Gelperin 8 Overview of Electronic Databases in Pharmacoepidemiology Brian L. Strom 9 Encounter Databases Tobi Gerhard, Yola Moride, Anton Pottegard, Nicole Pratt 10 Electronic Health Record Databases Daniel Horton, Harshvinder Bhullar, Francesca Cunningham, Janet Sultana B. Pharm (Hons.), and Gialuca Trifiro 11 Primary Data Collection for Pharmacoepidemiology Priscilla Velentgas 12 How Should One Perform Pharmacoepidemiologic Studies? Choosing Among the Available Alternatives Brian L. Strom Part III Special Issues in Pharmacoepidemiology Methodology 13 Validity of Drug and Diagnosis Data in Pharmacoepidemiology Mary Elizabeth Ritchey, Suzanne L West, and George Maldonado 14 Assessing Causality from Case Reports Bernard Begaud, and the late Judith K. Jones 15 Molecular Pharmacoepidemiology Christine Y Lu and Stephen E. Kimmel 16 Bioethical Issues in Pharmacoepidemiologic Research Laura E Bothwell, Annika Richterich, and Jeremy Greene 17 The Use of Randomized Controlled Trials in Pharmacoepidemiology Robert Reynolds, Samuel M. Lesko, Allen A. Mitchell 18 Pharmacoeconomics: Economic Evaluation of Pharmaceuticals Kevin A. Schulman 19 Patient Engagement and Patient Reported Outcomes Esi Morgan 20 The Use of Meta-analysis in Pharmacoepidemiology Jesse A. Berlin, Vrenda J Crowe, H Amy Xia, and Stephen JW Evans 21 Studies of Medication Adherence Julie Lauffenburger, Trisha Acri, and Robert Gross 22 Advanced Approaches to Controlling Confounding in Pharmacoepidemiologic Studies Sebastian Schneeweiss and Samy Suissa Part IV Special Applications and The Future of Pharmacoepidemiology 23 Special Applications of Pharmacoepidemiology, 339 David Lee, Björn Wettermark, Christine Y. Lu, Stephen B. Soumerai, Robert T. Chen, Sharon-Lise T. Normand, Art Sedrakyan, Danica Marinac-Dabic, Daniel B. Horton, Sonia Hernandez-Diaz, Tamar Lasky, Krista F. Huybrechts, Claudia Manzo, Emil Cochino, Hanna M. Seidling, David W. Bates, Bennett Levitan, Rachel DiSantostefano, Scott Evans Studies of Drug Utilization Evaluating and Improving Prescribing Special Methodological Issues in Pharmacoepidemiologic Studies of Vaccine Safety Epidemiologic Studies of Implantable Devices Research on the Effects of Medications in Pregnancy and in Children Risk Management The Pharmacoepidemiology of Medication Errors Benefit-Risk Assessments of Medical Treatments. 24 The Future of Pharmacoepidemiology Brian L. Strom, Stephen E. Kimmel, and Sean Hennessy Appendix A — Sample Size Tables Appendix B — Glossary Index
520			_a"It was a remarkable 32 years ago that the first edition of Strom's Pharmacoepidemiology was published. The preface to that book stated that pharmacoepidemiology was a new field with a new generation of pharmacoepidemiologists arising to join the field's few pioneers. Over the ensuing 32 years, the field indeed has grown and no longer deserves to be called "new." Many of those "new generation" scientists (including two of the editors of this book) are now "middle-aged" pharmacoepidemiologists. Despite its relatively brief academic life, a short history of pharmacoepidemiology and review of its current state will set the stage for the purpose of this textbook. Pharmacoepidemiology originally arose from the union of the fields of clinical pharmacology and epidemiology. Pharmacoepidemiology studies the use of and the effects of medical products in large numbers of people and applies the methods of epidemiology to the content area of clinical pharmacology. This field represents the science underlying postmarketing medical product surveillance, studies of the effects of medical products (i.e., drugs, biologicals, devices) performed after a product has been approved for use. In recent years, pharmacoepidemiology has expanded to include many other types of studies, as well"-- _cProvided by publisher.
545	0		_aAbout the Author About the Editors Brian L. Strom is Chancellor, Rutgers Biomedical and Health Sciences, University Professor, and Executive Vice President for Health Affairs, Rutgers University, Newark, NJ, USA. Stephen E. Kimmel is Dean’s Professor and Chair of Epidemiology, College of Public Health and Health Professions and College of Medicine, University of Florida, Gainesville, FL, USA. Sean Hennessy is Professor of Epidemiology and Director of the Center for Pharmacoepidemiology Research and Training, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
650		0	_aPharmacoepidemiology _0http://id.loc.gov/authorities/subjects/sh89004031 _xTextbooks. _0http://id.loc.gov/authorities/subjects/sh99001990.
650	1	2	_aPharmacoepidemiology _xmethods. _0https://id.nlm.nih.gov/mesh/D017891Q000379.
655		4	_aElectronic books.
700	1		_aStrom, Brian L., _0http://id.loc.gov/authorities/names/n88088423 _eeditor.
700	1		_aKimmel, Stephen E., _0http://id.loc.gov/authorities/names/n2006182085 _eeditor.
700	1		_aHennessy, Sean, _0http://id.loc.gov/authorities/names/n2011181845 _eeditor.
856	4	0	_uhttps://onlinelibrary.wiley.com/doi/book/10.1002/9781119701101 _yFull text is available at Wiley Online Library Click here to view
942			_2ddc _cER